These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32643913)

  • 1. Assessment of serotonin concentration in patients with a small-intestine neuroendocrine neoplasm and carcinoid syndrome treated with somatostatin analogues.
    Gut P; Czarnywojtek A; Sawicka-Gutaj N; Ruchała M
    Pol Arch Intern Med; 2020 Oct; 130(10):903-905. PubMed ID: 32643913
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of 5-hydroxyindoloacetic acid excretion in urine in patients with small intestine neuroendocrine neoplasm and carcinoid syndrome treated with somatostatin analogues.
    Gut P; Ruchała M
    Neuro Endocrinol Lett; 2019 Dec; 40(7-8):315-318. PubMed ID: 32304367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update of lanreotide acetate for treatment of adults with carcinoid syndrome.
    Guadalupe E; Deshpande HA; Stein SM
    Drugs Today (Barc); 2018 Aug; 54(8):457-465. PubMed ID: 30209440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telotristat ethyl for the treatment of carcinoid syndrome diarrhea not controlled by somatostatin analogues.
    Kasi PM
    Drugs Today (Barc); 2018 Jul; 54(7):423-432. PubMed ID: 30090879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of intestinal carcinoidosis].
    Grossi F; Grassi M
    Clin Ter; 1969 Sep; 50(5):475-80. PubMed ID: 4392675
    [No Abstract]   [Full Text] [Related]  

  • 6. [Parachlorophenylalanine and ultrastructure in the carcinoid syndrome].
    Rapado A; Oliva H; Traba ML; Díaz Recasens J; Ríuz F; Pérez-Corral F; Farré J; De la Barreda P
    Rev Clin Esp; 1974 Jan; 132(1):11-20. PubMed ID: 4276185
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A Review.
    Pasricha G; Padhi P; Daboul N; Monga DK
    Clin Ther; 2017 Nov; 39(11):2146-2157. PubMed ID: 29173655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grade 3 Neuroendocrine Tumor (G3 NET) in a Background of Multiple Serotonin Cell Neoplasms of the Ileum Associated with Carcinoid Syndrome and Aggressive Behavior.
    Capuano F; Grami O; Pugliese L; Paulli M; Pietrabissa A; Solcia E; Vanoli A
    Endocr Pathol; 2018 Dec; 29(4):369-373. PubMed ID: 30076568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Somatostatin analogs in the treatment of carcinoid syndrome: a case report and review of literature].
    Junik R; Kamińska A; Kamiński M; Ruprecht Z
    Pol Arch Med Wewn; 2003 Sep; 110(3):997-1001. PubMed ID: 14699693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of Carcinoid Heart Disease in Patients With Carcinoid Syndrome Initiating Somatostatin Analogues.
    Joish VN; Perez-Olle R; Lapuerta P; Dharba S; Zacks J
    Clin Ther; 2019 Sep; 41(9):1716-1723.e2. PubMed ID: 31326125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological and therapeutical (p-chlorphenylalanine) studies on the carcinoid syndrome].
    von Studnitz W; Waldenström J
    Verh Dtsch Ges Inn Med; 1971; 77():1322. PubMed ID: 5156018
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs.
    Kiesewetter B; Duan H; Lamm W; Haug A; Riss P; Selberherr A; Scheuba C; Raderer M
    Oncologist; 2019 Feb; 24(2):255-258. PubMed ID: 30171068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin analogues do not prevent carcinoid crisis.
    Guo LJ; Tang CW
    Asian Pac J Cancer Prev; 2014; 15(16):6679-83. PubMed ID: 25169508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety and unmet needs of evolving medical treatments for carcinoid syndrome.
    Koumarianou A; Daskalakis K; Tsoli M; Kaltsas G; Pavel M
    J Neuroendocrinol; 2022 Jul; 34(7):e13174. PubMed ID: 35794780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin does not prevent serotonin release and flushing during chemoembolization of carcinoid liver metastases.
    Zimmer C; Kienbaum P; Wiesemes R; Peters J
    Anesthesiology; 2003 Apr; 98(4):1007-11. PubMed ID: 12657865
    [No Abstract]   [Full Text] [Related]  

  • 16. Somatostatin Analogues in Neuroendocrine Tumors.
    Kulke MH
    J Natl Compr Canc Netw; 2016 Mar; 14(3):241-2. PubMed ID: 26957610
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinoid crisis after biopsy of a bronchial carcinoid.
    Karmy-Jones R; Vallières E
    Ann Thorac Surg; 1993 Dec; 56(6):1403-5. PubMed ID: 8267450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of somatostatin and salmon calcitonin on carcinoid syndrome. A clinical case].
    Festa V; Garrone C; Vietti Ramus G; Lisa F; Simone P; Scotti M; Cocchis D; Garrone GC
    Minerva Chir; 1989 May; 44(9):1429-33. PubMed ID: 2569698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review.
    Wolin EM; Benson Iii AB
    Oncology; 2019; 96(6):273-289. PubMed ID: 31018209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoid syndrome.
    Tilson MD
    Surg Clin North Am; 1974 Apr; 54(2):409-23. PubMed ID: 4593912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.